Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03259373 · ClinicalTrials.gov registry record · NA
IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
A NA study, sponsored by Harvard Pilgrim Health Care.
- Completed
- Registry status
- NA
- Development phase
- 64,666
- Enrollment target
NCT03259373 is a NA study that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 64,666 participants.
The verdict
NCT03259373, a NA study, has completed, sponsored by Harvard Pilgrim Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 64,666 participants
- Enrollment target
Study Summary
The purpose of this study is to use a decentralized claims database to determine whether education on stroke prevention in atrial fibrillation (AF) among AF patients and their providers can result in increased use of oral anticoagulants (OAC) for stroke prevention among those AF patients with guideline-based indications for oral anticoagulation (CHA₂DS₂-VASc score of 2 or greater). Specifically, the investigators will conduct a prospective, randomized, open-label education intervention trial to evaluate the effect of the early patient and provider education interventions on the proportion of patients with evidence of at least one OAC prescription fill (defined as one OAC dispensing or 4 international normalized ratio \[INR tests\] over the course of the follow-up through the date on which at least 80% of eligible study participants have at least 12 months of follow-up time). A total of approximately 80,000 patients will be enrolled within multiple major health plans across the United States. The randomization will be performed by the central coordinating center, and the health plans will mail the educational intervention materials to their members and providers.
Interventions
- BEHAVIORAL Early Patient-Level and Provider-Level Educational Intervention
- BEHAVIORAL Delayed Provider-Level Educational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64,666 participants |
| Start Date | 2017-09-25 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03259373
The ClinicalTrials.gov registry entry for NCT03259373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64,666 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Pilgrim Health Care, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Early Patient-Level and Provider-Level Educational Intervention is the first listed.
NCT03259373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03259373 about?
NCT03259373 is a clinical study titled "IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation". The purpose of this study is to use a decentralized claims database to determine whether education on stroke prevention in atrial fibrillation (AF) among AF patients and their providers can result in increased use of oral anticoagulants (OAC) for stroke prevention among those AF patients with guidel...
What is the current status of trial NCT03259373?
This trial is currently completed. It is a NA study. The enrollment target is 64,666 participants. The study started on 2017-09-25. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03259373?
The interventions under investigation include: Early Patient-Level and Provider-Level Educational Intervention (BEHAVIORAL), Delayed Provider-Level Educational Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03259373?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.